| Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 TN Starr, AJ Greaney, A Addetia, WW Hannon, MC Choudhary, ... Science 371 (6531), 850-854, 2021 | 793 | 2021 |
| Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate A Addetia, KHD Crawford, A Dingens, H Zhu, P Roychoudhury, ML Huang, ... Journal of clinical microbiology 58 (11), 10.1128/jcm. 02107-20, 2020 | 636 | 2020 |
| SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park, A Addetia, D Pinto, ... Nature 597 (7874), 97-102, 2021 | 457 | 2021 |
| Broad sarbecovirus neutralization by a human monoclonal antibody MA Tortorici, N Czudnochowski, TN Starr, R Marzi, AC Walls, F Zatta, ... Nature 597 (7874), 103-108, 2021 | 235 | 2021 |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages YJ Park, D Pinto, AC Walls, Z Liu, A De Marco, F Benigni, F Zatta, ... Science 378 (6620), 619-627, 2022 | 202 | 2022 |
| Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines JE Bowen, A Addetia, HV Dang, C Stewart, JT Brown, WK Sharkey, ... Science 377 (6608), 890-894, 2022 | 150 | 2022 |
| SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98 A Addetia, NAP Lieberman, Q Phung, TY Hsiang, H Xie, P Roychoudhury, ... MBio 12 (2), 10.1128/mbio. 00065-21, 2021 | 112 | 2021 |
| Neutralization, effector function and immune imprinting of Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Nature 621 (7979), 592-601, 2023 | 104 | 2023 |
| Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice AC Hunt, JB Case, YJ Park, L Cao, K Wu, AC Walls, Z Liu, JE Bowen, ... Science translational medicine 14 (646), eabn1252, 2022 | 100 | 2022 |
| Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain VK Outlaw, FT Bovier, MC Mears, MN Cajimat, Y Zhu, MJ Lin, A Addetia, ... MBio 11 (5), 10.1128/mbio. 01935-20, 2020 | 76 | 2020 |
| Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates A Addetia, H Xie, P Roychoudhury, L Shrestha, M Loprieno, ML Huang, ... Journal of Clinical Virology 129, 104523, 2020 | 75 | 2020 |
| Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State NF Müller, C Wagner, CD Frazar, P Roychoudhury, J Lee, LH Moncla, ... Science Translational Medicine 13 (595), eabf0202, 2021 | 67 | 2021 |
| Sensitive recovery of complete SARS-CoV-2 genomes from clinical samples by use of Swift Biosciences’ SARS-CoV-2 multiplex amplicon sequencing panel A Addetia, MJ Lin, V Peddu, P Roychoudhury, KR Jerome, AL Greninger Journal of clinical microbiology 59 (1), 10.1128/jcm. 02226-20, 2020 | 56 | 2020 |
| Architecture and antigenicity of the Nipah virus attachment glycoprotein Z Wang Biophysical Journal 121 (3), 29a, 2022 | 55 | 2022 |
| Persistent immune imprinting occurs after vaccination with the COVID-19 XBB. 1.5 mRNA booster in humans MA Tortorici, A Addetia, AJ Seo, J Brown, K Sprouse, J Logue, E Clark, ... Immunity 57 (4), 904-911. e4, 2024 | 48 | 2024 |
| International Spread of Multidrug-Resistant Campylobacter coli in Men Who Have Sex With Men in Washington State and Québec, 2015–2018 AL Greninger, A Addetia, K Starr, RJ Cybulski, MK Stewart, SJ Salipante, ... Clinical Infectious Diseases 71 (8), 1896-1904, 2020 | 34 | 2020 |
| Molecular features of the measles virus viral fusion complex that favor infection and spread in the brain C Mathieu, FT Bovier, M Ferren, NAP Lieberman, C Predella, A Lalande, ... MBio 12 (3), 10.1128/mbio. 00799-21, 2021 | 30 | 2021 |
| Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Biorxiv, 2023.01. 17.523798, 2023 | 29 | 2023 |
| Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape TN Starr, N Czudnochowski, F Zatta, YJ Park, Z Liu, A Addetia, D Pinto, ... BioRxiv, 2021 | 28 | 2021 |
| Comparative genomics and full-length Tprk profiling of Treponema pallidum subsp. pallidum reinfection A Addetia, LC Tantalo, MJ Lin, H Xie, ML Huang, CM Marra, AL Greninger PLOS Neglected Tropical Diseases 14 (4), e0007921, 2020 | 28 | 2020 |
